Polyrizon completes clinical site network for NASARIX study
Polyrizon says it has completed the clinical site network for its NASARIX study and is advancing toward patient enrollment, with no catalyst or timing details supplied.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.